1）Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: potential implications for metabolic and mitogenic activities.
Ciaraldi TP, Sasaoka T.
Horm Metab Res, 43: 1-10, 2011.

2）Both type I and II IFN induces insulin resistance by inducing different isoform of SOCS expression in 3T3-L1 adipocytes.
Wada T, Hoshino M, Kimura Y, Ojima M, Nakano T, Koya D, Tsuneki H, Sasaoka T.
Am J Physiol Endocrinol Metab, 300: E1112-E1123, 2011.

3）Indolizidine (-)-235B' and related structural analogs: Discovery of nicotinic receptor antagonists that inhibit nicotine-evoked [3H]dopamine release.
Pivavarchyk M, Smith AM, Zhang Z, Zhou D, Wang X, Toyooka N, Tsuneki H, Sasaoka T, McIntosh JM, Crooks PA, Dwoskin LP.
Eur J Pharmacol, 658: 132-139, 2011.